Transplant Genomics Licenses IP for Transplant Graft Status MDx | GenomeWeb

NEW YORK (GenomeWeb) – Transplant Genomics today announced a deal to exclusively license patent rights from The Scripps Research Institute and Northwestern University.

The Brookline, Mass.-based company will have access to intellectual property related to kidney and liver transplant diagnostics, such as immune status monitoring and optimization, and it intends to use the licensed technology develop and commercialize tests based on genomic biomarkers of transplant graft status. The tests would be used as part of a surveillance program to detect early signs of graft injury.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: new chromatin imaging approach, and more.

University of Wisconsin researchers uncover a mutation linked to Mauriac syndrome, which affects some children with type 1 diabetes.

Theranos has hired executives to oversee compliance and regulatory issues, the Wall Street Journal reports.

Chinese researchers to embark on a trial using a CRISPR/Cas9-based immunotherapy next month, Nature News reports.